Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Buclin

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Journal of Neuroimmunology|September 25, 1999
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markersL E Rothuizen, T Buclin, F Spertini, et al.
Renal Failure|May 9, 1998
Estimation of glomerular filtration rate by sinistrin clearance using various approachesT Buclin, R Sechaud, A P Bertschi, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administrationC Marzolini, L A Decosterd, F Shen, et al.
Praxis|May 28, 1997
[Voluntary mercury poisoning: biological consequences and psychiatric significance]P Jornod, M Vannotti, D R Dascal, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsT Buclin, J Biollaz, E A Lippa, et al.
Journal of Hypertension|April 1, 1999
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteersP Rousso, T Buclin, J Nussberger, et al.
British Journal of Cancer|May 14, 2008
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerabilityN Widmer, L A Decosterd, S Leyvraz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 25, 2010
An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patientsE Dahmane, T Mercier, B Zanolari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1995
Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinomaF Buchegger, J P Mach, A Pèlegrin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detectionN Widmer, A Béguin, B Rochat, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Journal of Neuroimmunology|September 25, 1999
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markersL E Rothuizen, T Buclin, F Spertini, et al.
Renal Failure|May 9, 1998
Estimation of glomerular filtration rate by sinistrin clearance using various approachesT Buclin, R Sechaud, A P Bertschi, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administrationC Marzolini, L A Decosterd, F Shen, et al.
Praxis|May 28, 1997
[Voluntary mercury poisoning: biological consequences and psychiatric significance]P Jornod, M Vannotti, D R Dascal, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsT Buclin, J Biollaz, E A Lippa, et al.
Journal of Hypertension|April 1, 1999
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteersP Rousso, T Buclin, J Nussberger, et al.
British Journal of Cancer|May 14, 2008
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerabilityN Widmer, L A Decosterd, S Leyvraz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 25, 2010
An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patientsE Dahmane, T Mercier, B Zanolari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1995
Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinomaF Buchegger, J P Mach, A Pèlegrin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detectionN Widmer, A Béguin, B Rochat, et al.
Pageof 11